Business Context and Reporting Period
Company: Genpact Limited
Filing Type: Form 8-K (Current Report)
Date of Report: March 29, 2017
Event: Execution of an accelerated share repurchase agreement.
Key Financial Metrics
This filing reports a specific capital allocation event rather than periodic financial performance metrics. The filing text does not provide values for revenue, profit, cash flow, margins, or total debt.
- Share Repurchase Commitment: $200 million aggregate value.
- Initial Payment: $200 million paid to the dealer (Morgan Stanley & Co. LLC) on March 30, 2017.
- Initial Shares Received: 6,578,947 shares.
- Funding Sources: Surplus cash, operating cash flows, and net proceeds from a private offering of 3.700% senior notes due 2022 by Genpact Luxembourg S.à r.l.
Material Changes
The primary material change is the reduction of outstanding shares and cash reserves due to the accelerated share repurchase. The final number of shares to be repurchased will be determined by the volume-weighted average share price during the transaction term, less a discount. Settlement is expected by the end of the fourth quarter of 2017.
Outlook, Risks, and Contingencies
Transaction Mechanics: At settlement, the dealer may be required to deliver additional shares to Genpact, or Genpact may be required to deliver shares or make a cash payment to the dealer, depending on share price performance and agreement terms.
Management Commentary: The transaction was executed pursuant to Genpact's existing share repurchase program.
Investor Verification Checklist
- Verify the final settlement date and total number of shares repurchased in the Q4 2017 10-K or subsequent 8-K filings.
- Confirm the impact of the $200 million cash outflow on the company's liquidity position in the next quarterly report.
- Review the terms of the 3.700% senior notes due 2022 to understand the debt service obligations associated with the funding source.
- Monitor any potential cash settlement adjustments required at the end of the transaction term.